Advertisement

Topics

Tumor-associated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer

18:00 EDT 28 Mar 2019 | Pharmaceutical Processing

A frontline chemotherapy drug is made less effective because similar compounds released by tumor-associated immune cells block the drug's action.
Contributed Author: 
Michigan Medicine - University of Michigan
Topics: 

Original Article: Tumor-associated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer

NEXT ARTICLE

More From BioPortfolio on "Tumor-associated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer"

Advertisement
Quick Search
Advertisement
Advertisement